Literature DB >> 18365662

DNA topoisomerases of Leishmania: the potential targets for anti-leishmanial therapy.

Benu Brata Das1, Agneyo Ganguly, Hemanta K Majumder.   

Abstract

Protozoan parasites of the genus Leishmania cause severe diseases that threaten human beings, both for the high mortality rates involved and the economic loss resulting from morbidity, primarily in the tropical and subtropical areas. This ancient eukaryote shows variable genetic diversity in their life cycle, wherein DNA topoisomerases play a key role in cellular processes affecting the topology and organization ofintracellular DNA. Kinetoplastid topoisomerases offer most attractive targets for their structural diversity from other eukaryotic counterparts and their indispensable function in cell biology Therefore, understanding the biology of kinetoplastid topoisomerases and the components and steps involved in this intricate process provide opportunities for target based drug designing against protozoan parasitic diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18365662     DOI: 10.1007/978-0-387-77570-8_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

1.  From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity.

Authors:  Emilie Durieu; Eric Prina; Olivier Leclercq; Nassima Oumata; Nicolas Gaboriaud-Kolar; Konstantina Vougogiannopoulou; Nathalie Aulner; Audrey Defontaine; Joo Hwan No; Sandrine Ruchaud; Alexios-Leandros Skaltsounis; Hervé Galons; Gerald F Späth; Laurent Meijer; Najma Rachidi
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 2.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

3.  Evaluation of the effect of Peganum harmala extracts on the in vitro viability of Leishmania tropica promastigotes in comparison to Glucantime.

Authors:  Manar Madah; Shaden Haddad; Mays Khazem
Journal:  J Parasit Dis       Date:  2020-09-27

4.  Target Identification and Intervention Strategies against Kinetoplastid Protozoan Parasites.

Authors:  Hemanta K Majumder; Wanderley de Souza; Kwang Poo Chang
Journal:  Mol Biol Int       Date:  2011-08-09

5.  Isobenzofuranone derivatives exhibit antileishmanial effect by inhibiting type II DNA topoisomerase and inducing host response.

Authors:  Amartya Mishra; Jayaraman Vinayagam; Sourav Saha; Sayan Chowdhury; Somenath Roy Chowdhury; Parasuraman Jaisankar; Hemanta K Majumder
Journal:  Pharmacol Res Perspect       Date:  2014-08-24

Review 6.  Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery.

Authors:  Rafael Balaña-Fouce; Raquel Alvarez-Velilla; Christopher Fernández-Prada; Carlos García-Estrada; Rosa M Reguera
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-24       Impact factor: 4.077

7.  Developments in diagnosis and antileishmanial drugs.

Authors:  Prachi Bhargava; Rajni Singh
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-18

8.  Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis.

Authors:  Nicholas J Gow; Robert N Davidson; Rob Ticehurst; Andrew Burns; Mark G Thomas
Journal:  PLoS Negl Trop Dis       Date:  2015-08-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.